124 related articles for article (PubMed ID: 11455194)
1. Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.
Tai DI; Tsai SL; Chen TC; Lo SK; Chang YH; Liaw YF
J Biomed Sci; 2001; 8(4):321-7. PubMed ID: 11455194
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the association between chronic hepatitis B and C infections and TNF-α (-308) gene polymorphism].
Börekçi G; Aras N; Kandemir Ö; Yalın S; Karakaş Çelik S; Berköz M
Mikrobiyol Bul; 2016 Apr; 50(2):236-44. PubMed ID: 27175496
[TBL] [Abstract][Full Text] [Related]
6. Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.
Wang L; Qiu J; Yu L; Hu X; Zhao P; Jiang Y
J Transl Med; 2014 Sep; 12():251. PubMed ID: 25199644
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study.
Lecube A; Hernández C; Genescà J; Simó R
Diabetes Care; 2006 May; 29(5):1096-101. PubMed ID: 16644643
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
Itoh Y; Okanoue T; Ohnishi N; Sakamoto M; Nishioji K; Nakagawa Y; Minami M; Murakami Y; Kashima K
Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
[TBL] [Abstract][Full Text] [Related]
9. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis.
Li JH; Zhu N; Min YB; Shi XZ; Duan YY; Yang YL
BMC Gastroenterol; 2018 Dec; 18(1):181. PubMed ID: 30518330
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.
Deng CL; Song XW; Liang HJ; Feng C; Sheng YJ; Wang MY
World J Gastroenterol; 2006 Mar; 12(11):1752-6. PubMed ID: 16586546
[TBL] [Abstract][Full Text] [Related]
12. T-lymphocyte subsets in peripheral blood and liver tissue of patients with chronic hepatitis B and C.
Dimitropoulou D; Karakantza M; Tsamandas AC; Mouzaki A; Theodorou G; Gogos CA
In Vivo; 2011; 25(5):833-40. PubMed ID: 21753143
[TBL] [Abstract][Full Text] [Related]
13. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Rossol S; Torre F; Wong PY; Gallati H; Portmann B; Williams R
Gastroenterology; 1995 May; 108(5):1453-63. PubMed ID: 7729638
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
17. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
Yamada Y; Webber EM; Kirillova I; Peschon JJ; Fausto N
Hepatology; 1998 Oct; 28(4):959-70. PubMed ID: 9755232
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in comparison to severity of morphological changes of the liver].
Lazareva AS; Volchkova EV; Umbetova KT; Chulanov VP; Parkhomenko IuG; Kiselevskiĭ MV; Pak SG
Ter Arkh; 2009; 81(4):55-60. PubMed ID: 19514423
[TBL] [Abstract][Full Text] [Related]
19. Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood.
Macías J; Sánchez-Quijano A; Pineda JA; Abad MA; Rubio A; Rosa R; Leal M; Lissen E
Liver; 2001 Dec; 21(6):410-4. PubMed ID: 11903886
[TBL] [Abstract][Full Text] [Related]
20. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
